Editorial Board About Us

Supplement

All articles from this category are listed below.

Volume 6, Supplement 10 Supplement

Overview of Samarium Sm 153 Lexidronam in the Treatment of Painful Metastatic Bone Disease

Prostate cancer Samarium Sm 153 lexidronam Metastatic bone disease Bone scan Radionuclides

Volume 6, Supplement 10 Supplement

Introduction: Advances in the Management of Prostate Cancer: The Emerging Role of ProstaScint and Quadramet

Michael K Brawer

Volume 6, Supplement 8 Supplement

Self-Assessment Post-Test

Michael K Brawer

Volume 6, Supplement 8 Supplement

The Changing Face of Urology in 2005

LHRH agonists Modifier 25 Centers for Medicare and Medicaid Services Health maintenance organizations Average sales price Evaluation and management services Practicemanagement information systems Electronic medical record Connectivity

Volume 6, Supplement 8 Supplement

Neoadjuvant Hormonal Therapy in Men Being Treated With Radiotherapy for Localized Prostate Cancer

Prostate cancer Radiotherapy External beam radiotherapy Randomized trials Neoadjuvant hormonaltherapy

Volume 6, Supplement 8 Supplement

A Critical Review of Maximal Androgen Blockade for Advanced Prostate Cancer

Gerald W Chodak

Prostate cancer Maximal androgen blockade Antiandrogens Combined androgen blockade Castration

Volume 6, Supplement 8 Supplement

The Evolving Definition of Advanced Prostate Cancer

Risk stratification Prostate-specific antigen Metastasis Recurrence Advanced prostate cancer Early hormonal therapy Biochemical recurrence Hormones

Volume 6, Supplement 8 Supplement

Androgen Deprivation Therapy: A Cornerstone in the Treatment of Advanced Prostate Cancer

Michael K Brawer

Androgen deprivation therapy Hormone therapy Mortality rates

Volume 6, Supplement 8 Supplement

Michael K Brawer

Volume 6, Supplement 7 Supplement

Self-Assessment Post-Test

E David Crawford